The Effects of Helicobacter pylori Eradication on Proteinuria in Patients with Primary Glomerulonephritis

Table 1

The baseline demographic, clinical, and laboratory features of the study patients.

	MN group (𝑛=35)	IgAN group (𝑛=12)	FSGS group (𝑛=12)	𝑃 value
Male/female	19/16	4/8	8/4	NS
Age (years)	46±14	40±13	42±15	NS
BMI (kg/m^2)	24.9±4.3	27.7±5.7	25.8±3.6	NS
Systolic BP (mmHg)	121±20	126±18	123±18	NS
Diastolic BP (mmHg)	75±12	81±16	79±13	NS
Hemoglobin (g/dL)	12.9±2.0	12.3±1.0	12.3±1.9	NS
Creatinine (mg/dL)	0.98±0.31	1.14±0.40	1.26±0.42	NS
Albumin (g/dL)	3.53±0.82	3.85±0.79	3.70±0.44	NS
T. cholesterol (mg/dL)	213±0.53	225±57	261±142	NS
Triglyceride (mg/dL)	177±128	188±126	214±115	NS
GFR (mL/min)	87±29	72±25	72±30	NS
Proteinuria (g/day)	2.76±3.10	2.04±1.60	3.55±2.69	NS

AMN: membranous nephropathy, IgAN: IgA nephropathy, FSGS: focal segmental glomerulosclerosis, NS: not significant, GFR: glomerular filtration rate.